ArticleJournal of gastrointestinal oncology2022

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab.

Yoshihiro Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.